[1]
Stachyra, B. et al. 2023. Tirzepatide - a novel dual GLP-1 and GIP receptor agonist used in pharmacotherapy of obesity: A literature review. Journal of Education, Health and Sport. 18, 1 (Apr. 2023), 23–33. DOI:https://doi.org/10.12775/JEHS.2023.18.01.003.